VitVio has opened its Vetro 3D computer-vision platform to hospitals nationwide, using ambient cameras and AI to track every movement in the operating room and pinpoint what's actually driving surgical delays and inefficiency.
Hexarad's AI workflow software OptiRad is now live across nine NHS sites in North East England and South Yorkshire, with one early-adopting trust reporting an 18% cut in scan turnaround times and £150,000 in annual savings.
Nvidia's GR00T-H surgical robotics AI model, trained on 778 hours of real operating room data across 35 organizations, is now commercially available, aiming to give device makers a shared foundation for semi-autonomous surgery.
As the FDA continues weighing national rules following a November 2025 advisory committee meeting, Illinois, Nevada and Utah have already enacted differing state laws on AI therapy chatbots in 2026, from outright bans to disclosure requirements, creating a fragmented compliance landscape.
HCA Healthcare and Google Cloud are piloting Nurse Handoff, a generative AI tool that standardizes shift-change patient handoffs at five hospitals, with nurses rating it accurate in over 85% of cases; the company plans to scale it to its 100,000-nurse workforce if results hold.
Sheba Medical Center has become the first hospital outside the U.S. to gain access to OpenAI's dedicated healthcare AI models, a deal signed in July 2026 that will bring ChatGPT Health to Israeli physicians for clinical decision support and documentation.
A Nature Medicine study led by researchers at Mount Sinai found ChatGPT Health under-triaged 52% of gold-standard emergency cases and showed inconsistent suicide-crisis safeguards, even as OpenAI expands the tool into major hospital systems.
A WHO/Europe report finds 74% of EU member states now use AI for medical diagnostics and 63% use patient-facing chatbots, but warns that workforce training on AI's limits is lagging just as EU AI Act transparency rules for medical devices take effect on August 2, 2026.
Ahead of a possible October IPO that could value it near $2 trillion, Anthropic is telling investors its healthcare and life-sciences push is central to its future — and to fixing public wariness of AI.
An APA survey of 1,242 psychologists found over 75 percent have patients discussing AI in therapy, with 93 percent expressing concern about chatbot use even as many acknowledged some patients feel supported by it.